发明授权
- 专利标题： Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
-
申请号： US16631192申请日： 2018-07-30
-
公开(公告)号： US11103493B2公开(公告)日： 2021-08-31
- 发明人: Hua Zhou , Xavier Fradera , Yongxin Han , Meredeth A. McGowan , Nunzio Sciammetta , Catherine White , Wensheng Yu
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 代理商 Yong Zhao; Anna L. Cocuzzo
- 国际申请： PCT/US2018/044274 WO 20180730
- 国际公布： WO2019/027856 WO 20190207
- 主分类号： A61K31/444
- IPC分类号： A61K31/444 ; A61K31/4439 ; A61K45/06 ; C07D401/08 ; C07D401/14 ; C07D471/04
摘要：
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
公开/授权文献
信息查询
IPC分类:
